MJJ Bank Of Montreal Microsectors Cannabis Etns
- 0.000
- 0.0000.00%
Easy-To-Trade Cannabis Stocks: Insights Into How Trading Activity Affects These Investments
The trading volume of a stock reflects the number of shares bought and sold within a given time. This is called liquidity. The term is used because it likens the ease of converting assets to cash to t
Cannabis Rescheduling: When Will It Happen? Expert Lays Out Timeline, Risks And Wild Cards
The Department of Justice (DOJ) confirmed that it has started the formal rulemaking process to reclassify cannabis to Schedule III. This significant step reinforces the positive outlook for cannabis stocks.
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). This shift could revolutionize the cannabis industry. B
Cannabis Stock Movers For May 17, 2024
GAINERS:Elixinol Wellness (OTC:ELLXF) shares closed up 116.00% at $0.01CordovaCann (OTC:LVRLF) shares closed up 29.04% at $0.07Heritage Cannabis Holding (OTC:HERTF) shares closed up 25.00% at $0.00Cha
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
Cantor Fitzgerald has initiated coverage on AbbVie Inc (NYSE:ABBV), a global pharma company.The analyst notes that the company has positioned itself to absorb Humira biosimilar erosion and achieve mod
What's Going On With Cannabis-Producer Akanda's Stock?
Akanda Corp. (NASDAQ:AKAN) shares are trading higher Friday amid increased volaility in marijuana stocks after President Biden announced the Department of Justice is taking the next step towards the r
Everything You Need to Know on Friday: Manulife's 20% Year-to-Date Stock Rise Reflects Long-Term Strategy, Says CEO
Good morning mooers! Here are things you need to know about today's market:
The Analyst Verdict: AbbVie In The Eyes Of 5 Experts
5 analysts have expressed a variety of opinions on AbbVie (NYSE:ABBV) over the past quarter, offering a diverse set of opinions from bullish to bearish.The following table summarizes their recent rati
Tilray Brands Files for Possible Sale of Shares
AbbVie Says It Will Present New Data Supporting Leading Gastroenterology Portfolio At 2024 Digestive Disease Week; Company To Present 15 Abstracts, Including Three Oral Presentations, In Crohn's Disease And Ulcerative Colitis
The 2024 Digestive Disease Week (DDW) Annual Meeting will be held on May 18-21 in Washington, D.C., and virtually.Data to be presented from the SEQUENCE head-to-head trial comparing risankizumab (SKYR
AbbVie Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/17/2024 21.69% Cantor Fitzgerald → $200 Initiates Coverage On → Overweight 04/29/2024 13.78% Barclays $
Cannabis Stock Gainers And Losers From May 16, 2024
GAINERS:Flower One Hldgs (OTC:FLOOF) shares closed up 900.00% at $1e-05Cannabix Technologies (OTC:BLOZF) shares closed up 28.41% at $0.60Greenlane Hldgs (NASDAQ:GNLN) shares closed up 16.06% at $0.61C
All Time Highs Came and Went | Wall Street Today
The market simmered from all-time highs Thursday morning to close lower with 7000 decliners compared to 5900 advancing equities. Still, the
Weed Industry Celebrates Biden's Rescheduling Move: 'Most Monumental Cannabis Reform In Half A Century'
Cannabis companies and legalization advocates are applauding President Joe Biden's Thursday announcement that formalizes the rescheduling process that will finally move cannabis from the DEA's Schedu
Weed Stocks Rally After Biden Makes Marijuana Reclassification Announcement
Shares of marijuana growers and cannabis-related companies are trading higher Thursday after President Biden announced that the Department of Justice has moved to reclassify marijuana from a Schedule
Biden Announces 'Monumental' Marijuana Rescheduling, DOJ To Take Next Steps
President Joe Biden announced on Thursday that his administration is officially moving to reschedule marijuana under federal law, while praising what he called a "monumental" step."Today my administra
Biden Administration Reportedly Moves to Reclassify Marijuana (Update)
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,000 Today
AbbVie (NYSE:ABBV) has outperformed the market over the past 5 years by 1.96% on an annualized basis producing an average annual return of 15.08%. Currently, AbbVie has a market capitalization of $288
Least Shorted S&P 500 Stocks as a Percentage of Float
Most Shorted S&P 500 Stocks as a Percentage of Float